| 标题 |
A 6-month Randomised, Double-blind, Placebo Controlled Multicentre Parallel Group Study to Evaluate Efficacy and Safety of Bumetanide 0.5mg Twice a Day Followed by an Open Label Active 6-month Treatment Period With Bumetanide (0.5mg Twice a Day) and a 6 Weeks Discontinuation Period After Treatment Stop
一项为期6个月的随机、双盲、安慰剂对照、多中心平行组研究,旨在评估布美他尼0.5 mg每日两次的疗效和安全性,随后是布美他尼开放标签活性6个月治疗期(0.5 mg每日两次)和治疗停止后6周的停药期
|
| 网址 | |
| DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |